398 related articles for article (PubMed ID: 14986248)
21. Fluoroquinolone resistance among Neisseria gonorrhoeae isolates in Hawaii, 1990-2000: role of foreign importation and increasing endemic spread.
Iverson CJ; Wang SA; Lee MV; Ohye RG; Trees DL; Knapp JS; Effler PV; O'connor NP; Levine WC
Sex Transm Dis; 2004 Dec; 31(12):702-8. PubMed ID: 15608583
[TBL] [Abstract][Full Text] [Related]
22. Dramatic increase in a single genotype of TRNG ciprofloxacin-resistant Neisseria gonorrhoeae isolates in men who have sex with men.
Palmer HM; Young H
Int J STD AIDS; 2006 Apr; 17(4):254-6. PubMed ID: 16595048
[TBL] [Abstract][Full Text] [Related]
23. What is new with antibiotic-resistant gonorrhoea in Newcastle, England?
Elawad BB; Narayanan M; Pattman RS; Sankar KN; Freeman R
Int J STD AIDS; 2002 Dec; 13(12):805-8. PubMed ID: 12537730
[TBL] [Abstract][Full Text] [Related]
24. Molecular epidemiology of endemic ciprofloxacin-resistant Neisseria gonorrhoeae in Liverpool.
Corkill JE; Komolafe AJ; Neal TJ; Mortimore A; Alawattegama AB; Hart CA
Int J STD AIDS; 2003 Jun; 14(6):379-85. PubMed ID: 12816664
[TBL] [Abstract][Full Text] [Related]
25. Single dose (direct observed) azithromycin therapy for Neisseria gonorrhoeae and Chlamydia trachomatis in STD clinic attenders with genital discharge in Trinidad and Tobago.
Swanston WH; Prabhakar P; Barrow L; Mahabir BS; Furlonge C
West Indian Med J; 2001 Sep; 50(3):198-202. PubMed ID: 11769023
[TBL] [Abstract][Full Text] [Related]
26. Fluoroquinolone-resistant Neisseria gonorrhoeae: the inevitable epidemic.
Ghanem KG; Giles JA; Zenilman JM
Infect Dis Clin North Am; 2005 Jun; 19(2):351-65. PubMed ID: 15963876
[TBL] [Abstract][Full Text] [Related]
27. Ciprofloxacin resistant Neisseria gonorrhoeae in South Africa.
Moodley P; Moodley D; Willem Sturm A
Int J Antimicrob Agents; 2004 Aug; 24(2):192-3. PubMed ID: 15288322
[No Abstract] [Full Text] [Related]
28. Epidemiological characteristics and molecular basis of fluoroquinolone-resistant Neisseria gonorrhoeae strains isolated in Korea and nearby countries.
Yong D; Kim TS; Choi JR; Yum JH; Lee K; Chong Y; Oh HB; Shultz T; Tapsall JW
J Antimicrob Chemother; 2004 Aug; 54(2):451-5. PubMed ID: 15231766
[TBL] [Abstract][Full Text] [Related]
29. Changing epidemiologic profile of quinolone-resistant Neisseria gonorrhoeae in London.
Martin IM; Ison CA; Aanensen DM; Fenton KA; Spratt BG
J Infect Dis; 2005 Oct; 192(7):1191-5. PubMed ID: 16136461
[TBL] [Abstract][Full Text] [Related]
30. From the Centers for Disease Control and Prevention. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.
JAMA; 2002 Dec; 288(23):2961-3. PubMed ID: 12492093
[No Abstract] [Full Text] [Related]
31. Molecular epidemiology of Neisseria gonorrhoeae exhibiting decreased susceptibility and resistance to ciprofloxacin in Hawaii, 1991-1999.
Trees DL; Sandul AL; Neal SW; Higa H; Knapp JS
Sex Transm Dis; 2001 Jun; 28(6):309-14. PubMed ID: 11403186
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial resistance pattern of Neisseria gonorrhoeae isolates from peripheral health centres and STD clinic attendees of a tertiary care centre in India.
Bala M; Ray K; Gupta SM
Int J STD AIDS; 2008 Jun; 19(6):378-80. PubMed ID: 18595874
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.
Heffernan H; Brokenshire M; Woodhouse R; MacCarthy A; Blackmore T
N Z Med J; 2004 Apr; 117(1191):U817. PubMed ID: 15107886
[TBL] [Abstract][Full Text] [Related]
34. Suboptimal therapy and clinical management of gonorrhoea in an area with high-level antimicrobial resistance.
Chen PL; Hsieh YH; Lee HC; Ko NY; Lee NY; Wu CJ; Chang CM; Lee CC; Ko WC
Int J STD AIDS; 2009 Apr; 20(4):225-8. PubMed ID: 19304963
[TBL] [Abstract][Full Text] [Related]
35. Increasing incidence of gonorrhea in Israel associated with countrywide dissemination of a ciprofloxacin-resistant strain.
Yagupsky P; Schahar A; Peled N; Porat N; Trefler R; Dan M; Keness Y; Block C
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):368-72. PubMed ID: 12072921
[TBL] [Abstract][Full Text] [Related]
36. Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae.
Matsumoto T
Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S35-9. PubMed ID: 18164598
[TBL] [Abstract][Full Text] [Related]
37. The role of fluoroquinolones in sexually transmitted diseases.
Tartaglione TA; Hooton TM
Pharmacotherapy; 1993; 13(3):189-201. PubMed ID: 8321733
[TBL] [Abstract][Full Text] [Related]
38. Risk factors and characteristics of patients with gonorrhoea presenting to Auckland Sexual Health Service, New Zealand.
Azariah S; Perkins N
N Z Med J; 2007 Apr; 120(1252):U2491. PubMed ID: 17460741
[TBL] [Abstract][Full Text] [Related]
39. Increasing rates of quinolone-resistant Neisseria gonorrhoeae in Paris, France.
Farhi D; Gerhardt P; Falissard B; Poupet H; Poyart C; Dupin N
J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):818-21. PubMed ID: 17567314
[TBL] [Abstract][Full Text] [Related]
40. High incidence of treatment failure of Neisseria gonorrhoeae isolates to ciprofloxacin in male gonococcal urethritis in Delhi.
Chowdhry S; Pandhi D; Vidhani S; Bhalla P; Reddy BS
Int J STD AIDS; 2002 Aug; 13(8):564-7. PubMed ID: 12194741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
